---
title: "Enveric Biosciences to Explore and Negotiate Potential Digital Asset Treasury Strategy Opportunities to Support Long-Term Growth"
description: "Enveric Biosciences Inc. has authorized its Capital Markets Committee to explore potential Digital Asset Treasury strategy opportunities. This initiative aims to enhance shareholder value and support "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261075275.md"
published_at: "2025-10-14T13:00:34.000Z"
---

# Enveric Biosciences to Explore and Negotiate Potential Digital Asset Treasury Strategy Opportunities to Support Long-Term Growth

> Enveric Biosciences Inc. has authorized its Capital Markets Committee to explore potential Digital Asset Treasury strategy opportunities. This initiative aims to enhance shareholder value and support long-term growth while focusing on its core biotechnology programs. Any agreements will require further review and approval by the full Board. Updates will follow as developments occur.

Enveric Biosciences Inc. announced that its Board of Directors has authorized the Capital Markets Committee to explore and negotiate non-binding term sheets for potential Digital Asset Treasury (DAT) strategy opportunities. These opportunities will be subject to further review and approval by the full Board. The company stated that this initiative aims to enhance shareholder value and support long-term growth, while maintaining a focus on advancing its core biotechnology programs. Further updates will be provided as developments occur. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251014229096) on October 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [ENVB.US - Enveric Biosciences](https://longbridge.com/en/quote/ENVB.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Enveric Biosciences Announces 1-for-12 Reverse Stock Split | Enveric Biosciences Inc. will execute a 1-for-12 reverse stock split of its common stock, effective October 28, 2025. Th | [Link](https://longbridge.com/en/news/262429613.md) |
| Enveric Biosciences to Present at Sachs Neuroscience Innovation Forum and Biotech Showcase | Enveric Biosciences Inc. will present and participate in a panel discussion at the Sachs Neuroscience Innovation Forum o | [Link](https://longbridge.com/en/news/268614222.md) |
| Enad Global 7 Withdraws 2026 Financial Targets | Enad Global 7 AB has withdrawn its financial targets for 2026, including SEK 3 billion in revenue and SEK 1 billion in a | [Link](https://longbridge.com/en/news/276101273.md) |
| Does ESOP Shelf Registration and Indoor Wellness Push Change The Bull Case For Scotts Miracle-Gro (SMG)? | Scotts Miracle-Gro filed a US$183.34 million shelf registration for 2,750,000 common shares linked to an ESOP offering a | [Link](https://longbridge.com/en/news/276107860.md) |
| TELUS a 'Structural Leader' That Can Maintain Premium Valuation, RBC Says | RBC Capital Markets views TELUS (TU) as a 'structural leader' capable of maintaining its premium valuation through 2026- | [Link](https://longbridge.com/en/news/275933921.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.